PMID: 42190805

Rituximab in anti-HMG-CoA reductaseimmune-mediated necrotizing myopathyrefractory to treatment.

Pato-Pato A, López-Díaz L M, Herrero-Poch L, Fortes-González M S

Neurologia · 2026

pp. 502030

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.